University of Miami's 2nd Biennial Miami Leukemia Symposium

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
Avatar

Relapsed/Refractory ALL: Both Inotuzumab and Blinatumomab Are Superior to Standard Chemotherapy With Regards to Remission Rates and Survival

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Daniel J. DeAngelo
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Daniel J. DeAngelo
315 views
May 14, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
ALL Biology and Treatment
24:06

ALL Frontline Therapy for Young Adults: Building Upon a Successful “…

University of Miami's 2nd Biennial Miami Leukemia Symposium

W. Stock

200 views
20:50

Relapsed/Refractory ALL: Both Inotuzumab and Blinatumomab Are Superi…

University of Miami's 2nd Biennial Miami Leukemia Symposium

D. DeAngelo

315 views